Literature DB >> 12634954

Zidovudine-related anemia with reticulocytosis.

P R Koduri1, S Parekh.   

Abstract

In patients infected with human immunodeficiency virus (HIV), zidovudine has been known to cause a severe hypoproliferative anemia that resolves promptly when the drug is stopped. Some patients, however, may come to medical attention after having stopped taking the drug for 1-2 weeks and may already be in the recovery phase and present with severe anemia, normoblastemia, and reticulocytosis. These features can be mistaken for hemolytic disease, as shown by our experience with three such patients.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12634954     DOI： 10.1007/s00277-002-0587-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  5 in total

1.  Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: an Effective Nano First-Line Regimen for HIV Therapy.

Authors:  Prashant Kumar; Yeruva Samrajya Lakshmi; Anand K Kondapi
Journal:  Pharm Res       Date:  2016-12-07       Impact factor: 4.200

2.  Adverse drug reactions to antiretroviral therapy: prospective study in children in sikasso (mali).

Authors:  Aboubacar A Oumar; Korotoumou Diallo; Jean P Dembélé; Lassana Samaké; Issa Sidibé; Boubacar Togo; Mariam Sylla; Anatole Tounkara; Sounkalo Dao; Paul M Tulkens
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

3.  Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy.

Authors:  B Akshaya Srikanth; S Chandra Babu; Harlokesh Narayan Yadav; Sunil Kumar Jain
Journal:  J Adv Pharm Technol Res       Date:  2012-01

4.  Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience.

Authors:  Aboubacar Alassane Oumar; Mamadou Dakouo; Anicet Tchibozo; Mamoudou Maiga; Guida Landouré; Raysso Abdi-Bogoreh; Paul M Tulkens; Sounkalo Dao; Jean Cyr Yombi
Journal:  Int J Basic Clin Pharmacol       Date:  2019-05

5.  Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.

Authors:  Henry Namme Luma; Marie-Solange Doualla; Simeon-Pierre Choukem; Elvis Temfack; Gloria Ashuntantang; Henry Achu Joko; Sinata Koulla-Shiro
Journal:  Pan Afr Med J       Date:  2012-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.